Clinical Trial Results
Clinical Trial
Results
Research Sponsor: AstraZeneca AB
Drugs Studied: Formoterol
National Clinical Trial #: NCT02796651
Protocol #: D6571C00002
Study Date: June 2016 to December 2016
Short Study Title: A study to learn if formoterol taken at different doses in a certain type
of inhaler is effective at treating COPD, and if formoterol taken in this
inhaler is safe to use.
Thank you!
As a clinical study participant, you belong to a large community of participants around
the world. You help researchers answer important health questions and discover new
medical treatments.
Thank you for taking part in the clinical study for a drug called formoterol. This drug has been
approved to treat chronic obstructive pulmonary disease, also known as COPD, and asthma.
You and all of the other participants helped researchers learn if formoterol taken in a certain
dose and type of inhaler helps people with COPD, and if the drug is safe to use.
AstraZeneca AB, the sponsor of this study, thanks you for your help and thinks it is important
for you to know the results of your study. An independent non-profit organization called
CISCRP prepared this summary of the study results for you with the help of a medical writing
organization. We hope it helps you understand and feel proud of your important role in medical
research. If you have questions about the results, please speak with the study doctors or staff at
your study site.
1